The Ministry of Food and Drug Safety on Tuesday canceled the license for Invossa, the first drug in the world to use gene therapy to treat knee osteoarthritis. The scandal over Invossa threatens to derail the government’s fourth industrial revolution strategy.
with the Korea JoongAng Daily
To write comments, please log in to one of the accounts.
Standards Board Policy (0/250자)